Events & Seminars
International Symposium
L6 2018 Senri Life Science International Symposium
“A New Horizon of Cancer Immunotherapy”
| Date & Time | January 19th (Friday), 2018, 10:00-17:00 |
|---|---|
| Coordinators | Nagahiro Minato Provost, Executive Vice President, Kyoto University Project-leading Professor, Graduate School of Medicine, Kyoto University Keiya Ozawa Director, The Institute of Medical Science, The University of Tokyo (IMSUT) Hospital Director, Center for Gene & Cell Therapy (CGCT) Professor, Division of Genetic Therapeutics, The Advanced Clinical Research Center IMSUT |
Program
| Talk 1 | Tumor and host factors regulating anti-tumor immunity and immunotherapy efficacy
Thomas F. Gajewski
University of Chicago, USA
|
|---|---|
| Talk 2 | Donor-derived immunity in cancer immunotherapy
Johanna Olweus
Oslo University Hospital Radiumhospitalet, Norway
|
| Talk 3 | Immune Checkpoint Blockade and Beyond in Cancer Immunity
Nagahiro Minato
Kyoto University, Japan
|
| Talk 4 | Response and Resistance to PD-1 Blockade Therapy
Antoni Ribas
Jonsson Comprehensive Cancer Center at UCLA, USA
|
| Talk 5 | Recent trends of clinical gene therapy, focusing on CAR-T cell therapy
Keiya Ozawa
The University of Tokyo, Japan
|
| Talk 6 | CAR T cell therapy beyond the CD19 paradigm
Michel Sadelain
Memorial Sloan Kettering Cancer Center, USA
|
| Talk 7 | Developing effective adoptive T cell therapy for solid tumors
Daniel J. Powell Jr.
University of Pennsylvania, USA
|
Share
